TP53 and cancer: Surface modification of folate to target the folate receptor expressed in cancer cells can improve drug delivery efficiency due to intracellular signaling of the folate receptor, which leads to an increase in the cancer suppressor protein P53, thus enabling cancer cells to die more quickly [16].